• Claire Thompson

    Agility Life Sciences

    Episode 15

    Owning your authenticity

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults

    Read more
  • Kevin Orfan

    Sharp

    Episode 14

    Building robust and scalable systems

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Orfan, President at Sharp. Kevin has been in the pharmaceutical and medical device industry for over 30 years and has incredible experience in the contract manufacturing space. He began his pharma career at Abbott

    Read more
  • Jeffrey Kiplinger

    Cohere Business Strategies

    Episode 13

    Entrepreneurship in the life science sector

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey Kiplinger, Co-Founder of Cohere Business Strategies and advisor and coach for entrepreneurs in the life sciences space. Jeffrey Co-Founded Research Operations Group in 2000, founded Averica Discovery Services in 2007, and has over 35

    Read more
  • Gil Roth

    Pharma & Biopharma Outsourcing Association

    Episode 12

    Advocating for the CDMO sector

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA). Previous to launching PBOA in 2014, Gil helped launch Contract Pharma in 1999 and served as the founding editor for 15 years.

    Read more
  • Dexter Tjoa

    Tjoapack

    Episode 11

    The benefits of postponement packaging

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dexter Tjoa, CEO at Tjoapack. With a master’s from Oxford University, Dexter joined Tjoapack about 5 years ago. His career has accelerated at an incredible speed since taking over the family business from his father,

    Read more
  • Bobby Sheng

    Bora Pharmaceuticals

    Episode 10

    Taking the family-owned CDMO global

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng, CEO and Chairman of Bora Pharmaceuticals. A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from

    Read more
  • John Ross

    Mayne Pharma / Metrics Contract Services

    Episode 9

    The increasing demand for HPAPI

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013

    Read more
  • Michael Quirmbach

    Corden Pharma

    Episode 8

    A CDMO on the Covid-19 frontline

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and

    Read more
  • Eugene Ciolfi

    MedPharm

    Episode 7

    Learnings from 30 years in the CDMO space

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene

    Read more
  • Detlef Behrens

    Bay Pharma

    Episode 6

    The importance of positive, disruptive thinking

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens, founder at Bay Pharma. A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now

    Read more